Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | S&P Health Care Select Sector Daily Capped 35/20 |
| Investment focus | Equity, United States, Health Care |
| Fund size | EUR 525 m |
| Total expense ratio | 0.15% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 15.77% |
| Inception/ Listing Date | 7 July 2015 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | State Street |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Fund Services (Ireland) Limited |
| Investment Advisor | State Street Global Advisors Europe Limited |
| Custodian Bank | State Street Custodial Services (Ireland) Limited |
| Revision Company | Ernst & Young |
| Fiscal Year End | 31 March |
| Swiss representative | State Street Bank International GmbH, München, Zweigniederlassung Zürich |
| Swiss paying agent | State Street Bank International GmbH, München, Zweigniederlassung Zürich |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | State Street Bank and Trust Company |
| Securities lending | Yes |
| Securities lending counterparty | BARCLAYS BANK PLC|BARCLAYS CAPITAL SECURITIES LIMITED|BNP PARIBAS|BNP PARIBAS ARBITRAGE SNC|CITIGROUP GLOBAL MARKETS LIMITED|CREDIT SUISSE INTERNATIONAL|GOLDMAN SACHS INTERNATIONAL|HSBC BANK PLC|ING BANK NV|JP MORGAN SECURITIES PLC|MACQUARIE BANK LIMITED|MERRILL LYNCH INTERNATIONAL|MORGAN STANLEY & CO. INTERNATIONAL PLC.|NOMURA INTERNATIONAL PLC|RBC EUROPE LIMITED|SOCIETE GENERALE SA|UBS AG |
| Eli Lilly & Co. | 14.91% |
| Johnson & Johnson | 10.43% |
| AbbVie, Inc. | 7.38% |
| Merck & Co., Inc. | 5.95% |
| UnitedHealth Group Inc | 5.76% |
| Amgen, Inc. | 3.78% |
| Thermo Fisher Scientific, Inc. | 3.74% |
| Abbott Laboratories | 3.13% |
| Gilead Sciences, Inc. | 2.96% |
| Pfizer Inc. | 2.64% |
| United States | 97.73% |
| Ireland | 2.27% |
| Other | 0.00% |
| Healthcare | 98.05% |
| Consumer Non-Cyclicals | 1.95% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| | 0.00 € | 0.00 € | View offer** | |
| | 0.00 € | 0.00 € | View offer* | |
| | 0.00 € | 0.00 € | View offer* | |
| | 0.00 € | 0.00 € | View offer* | |
| | 0.00 € | 0.00 € | View offer* |
| Broker | Rating | Order fee | ETF savings plans | |
|---|---|---|---|---|
| | 0.99 € | 3646 | View offer** | |
| | 0.00 € | 2603 | View offer* | |
| | 0.95 € | 2530 | View offer* | |
| | 1.00 € | 2986 | View offer* | |
| | 0.00 € | 1868 | View offer* |
| YTD | +16.86% |
| 1 month | +7.04% |
| 3 months | +7.80% |
| 6 months | +20.04% |
| 1 year | +24.34% |
| 3 years | +28.13% |
| 5 years | +48.39% |
| Since inception (MAX) | +158.90% |
| 2025 | +0.89% |
| 2024 | +8.70% |
| 2023 | -1.88% |
| 2022 | +3.73% |
| Volatility 1 year | 15.77% |
| Volatility 3 years | 15.45% |
| Volatility 5 years | 16.12% |
| Return per risk 1 year | 1.54 |
| Return per risk 3 years | 0.56 |
| Return per risk 5 years | 0.51 |
| Maximum drawdown 1 year | -10.92% |
| Maximum drawdown 3 years | -22.26% |
| Maximum drawdown 5 years | -22.26% |
| Maximum drawdown since inception | -27.78% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | ZPDH | - - | - - | - |
| Stuttgart Stock Exchange | EUR | ZPDH | - - | - - | - |
| Bolsa Mexicana de Valores | MXN | - | SXLVN MM | SXLVN.MX | |
| Borsa Italiana | EUR | SXLV | SXLV IM INZPDHE | SXLV.MI | BNP DRW Flow Traders Jane Street Optiver Virtu |
| Euronext Amsterdam | EUR | SXLV | SXLV NA INZPDHE | SXLV.AS | BAADER BANK BNP DRW Flow Traders Optiver Virtu |
| London Stock Exchange | USD | SXLV | SXLV LN INZPDHU | SXLV.L | BAADER BANK AG BNP DRW Flow Traders Old Mission Europe LLP Optiver Virtu |
| London Stock Exchange | GBP | GXLV | GXLV LN INZPDHP | GXLV.L | BAADER BANK AG BNP DRW Flow Traders Old Mission Europe LLP Optiver Virtu |
| SIX Swiss Exchange | USD | SXLV | SXLV SE INZPDHU | SXLV.S | BNP DRW Finovesta Flow Traders Optiver Virtu |
| XETRA | EUR | ZPDH | ZPDH GY INZPDHE | ZPDH.DE | BNP Flow Traders Optiver |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares S&P 500 Health Care Sector UCITS ETF (Acc) | 2,840 | 0.15% p.a. | Accumulating | Full replication |
| iShares Nasdaq US Biotechnology UCITS ETF | 1,049 | 0.35% p.a. | Accumulating | Sampling |
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 850 | 0.12% p.a. | Distributing | Full replication |
| Invesco US Health Care Sector UCITS ETF | 487 | 0.14% p.a. | Accumulating | Swap-based |
| Invesco Nasdaq Biotech UCITS ETF | 428 | 0.40% p.a. | Accumulating | Swap-based |